Test Price
2,800 AEDโ Home Collection Available
MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
A definitive next-generation sequencing (NGS) test for diagnosing congenital disorder of glycosylation type IIa (CDG-IIa) caused by pathogenic variants in the MGAT2 gene. This test delivers 99.9% diagnostic sensitivity through ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a DHA-licensed specialist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Facility License: DHA License No. 1143.
Test Overview & Methodology
This comprehensive NGS test analyzes the entire MGAT2 gene โ including all coding exons, splice junctions, and deep intronic regions โ to detect pathogenic variants responsible for congenital disorder of glycosylation type IIa (CDG-IIa). The assay utilizes LC-MS/MS validated sequencing chemistry to achieve greater than 99.9% sensitivity for clinically actionable mutations. Definitive diagnosis via this test enables accurate carrier detection, informed family planning, and tailored lifelong management strategies for affected individuals.
| Feature | Our Genetic Test | Closest Alternative (Biochemical Screening) |
|---|---|---|
| Method | Full MGAT2 NGS (LCโMS/MS validated) | Transferrin Isoelectric Focusing / Enzyme Assay |
| Diagnostic Precision | >99.9% sensitivity for pathogenic variants | Moderate; often requires confirmatory genetic test |
| Speed (TAT) | 3โ4 Weeks | 2โ3 days (but not conclusive) |
| Coverage | All coding exons, splice junctions, deep intronic regions | Indirect evidence of abnormal glycosylation |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
โThis NGS test for the MGAT2 gene provides a definitive molecular diagnosis for congenital disorder of glycosylation type IIa. The results must be interpreted alongside clinical presentation and biochemical markers. I recommend that families receive pre-test and post-test counseling to fully understand the implications for management and reproductive planning.โ
Advisory Notice โ Do Not Alter Medications Without Medical Guidance
Do not discontinue or modify any prescribed medication without consulting your treating physician. This genetic test is a diagnostic tool and does not replace acute medical care or emergency intervention.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Recent blood transfusion (within 2 weeks), active uncontrolled infection, or inability to provide a blood or FTA card sample.
- Emergency Red Flags: If you experience sudden severe lethargy, persistent vomiting, seizures, or signs of a metabolic crisis, seek immediate medical attention โ do not wait for test results.
Patient FAQ & Clinical Guidance
1. What does the MGAT2 gene test diagnose?
The MGAT2 NGS test definitively detects pathogenic variants in the MGAT2 gene responsible for congenital disorder of glycosylation type IIa (CDG-IIa). This rare inherited condition affects protein glycosylation and can present with developmental delay, seizures, and coagulopathy. Early genetic diagnosis enables targeted management and family counseling.
2. How is the sample collected and when will I get results?
A painless blood draw or FTA card sample is collected through our VIP Mobile Phlebotomy service at your home between 8 AM and 11 PM. Results are delivered within 3โ4 weeks and include a detailed clinical report with variant interpretation and management recommendations.
3. Is this test covered by insurance, and how can I verify coverage?
We verify full insurance coverage directly via WhatsApp (+971 54 548 8731). Most UAE health insurance plans cover diagnostic genetic testing when ordered by a qualified physician and deemed medically necessary. We recommend contacting us before scheduling to confirm your specific policy benefits.
4. Who should consider taking this genetic test?
This test is indicated for individuals with clinical suspicion of a congenital disorder of glycosylation, particularly those presenting with unexplained developmental delay, hypotonia, seizures, liver dysfunction, or abnormal coagulation studies. It is also appropriate for carrier testing in families with a known MGAT2 mutation and for prenatal diagnosis in at-risk pregnancies.
5. How should I prepare for the test and what aftercare is provided?
No special preparation is required. After your sample is collected, you will receive a telephonic consultation with a DHA-licensed specialist to discuss your results in detail. A secure copy of your report is also made available through our patient portal for your records and for sharing with your healthcare provider.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Rights โ Fully Compliant with UAE Law
This test and all associated data handling are conducted in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds DHA Facility License No. 1143 and adheres to the highest standards of genetic data confidentiality and ethical practice.
Clinical & Logistical Metadata
| Test Name | MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with LC-MS/MS Validation |
| ICD-10-CM Code | E77.8 |
| LOINC Code | 51966-7 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians